RxDoctor Payments Data

Tarah Wright

Psychiatric/Mental Health · Medford, NJNPI 1710453121

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,855 of the $4,402 with a category attached, or 87.6%. It is spread thinly across 21 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,834, 2.9 times the $637 reported in 2021. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,402in general payments, 2019–2025

Across 217 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$638
  • AbbVie$627
  • Otsuka America Pharmaceutical, Inc.$558
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$419
  • Ironshore Pharmaceuticals Inc.$373
  • Alkermes, Inc.$268
  • plus $2K from 15 others

What the payments were for

  • Speaking & faculty fees$50011%
  • Food & beverage$3,85588%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,402 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey →

Medicare billing

Part B allowed, 2024
$17,050
Medicare patients
48
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole48$3,144
Lisdexamfetamine Dimesylate11$3,011
Bupropion XlBupropion Hcl100$2,404
Duloxetine Hcl58$1,403
Clonazepam136$899
Buspirone Hcl21$894
Fluoxetine Hcl44$853
Trazodone Hcl87$824
Venlafaxine Hcl ErVenlafaxine Hcl33$787
Alprazolam98$556
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$537
Mirtazapine23$536
Gabapentin29$456
Lamotrigine39$443
Escitalopram Oxalate42$304

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Medford

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →